Spooner Chad 4

What Happened
Chad Spooner, Chief Financial Officer of MiniMed Group, Inc. (MMED), was granted a total of 269,401 restricted stock units (RSUs) on March 11, 2026. These RSUs were issued as a conversion of previously held Medtronic equity awards in connection with MiniMed’s separation from Medtronic, and were granted under MiniMed’s 2026 Long Term Incentive Plan (LTIP). No cash purchase or open-market trade occurred — these are awards (transaction code A), not sales or purchases.

Key Details

• Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (filed timely).
• Shares granted (total): 70,896 + 127,609 + 70,896 = 269,401 RSUs. Reported acquisition price: N/A (awards).
• Vesting schedules (per filing footnotes):
  • 70,896 RSUs vest on April 28, 2028. (F3)
  • 127,609 RSUs vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028. (F5)
  • 70,896 RSUs vest on July 28, 2028. (F6)
• Conversion mechanics: The RSUs resulted from conversion of Medtronic restricted stock units and performance share units pursuant to the Employee Matters Agreement (EMA) tied to the March 9, 2026 separation; conversion used average Medtronic and MMED share prices over specified windows. (F1, F2)
• Shares to be issued include amounts tied to vesting of one or more RSUs (F4).
• Shares owned following the transaction are not specified in the reported data.

Context
These awards reflect a conversion of legacy Medtronic equity into MiniMed RSUs as part of the corporate separation — not a new cash purchase or a sale. RSUs are time‑vesting grants: they become actual shares only as they vest per the schedules above. For retail investors, such converted awards are routine in spin-offs or separations and do not alone indicate insider buying or selling intent.